Literature DB >> 28394427

Opioid system and human emotions.

Lauri Nummenmaa1, Lauri Tuominen2.   

Abstract

Emotions are states of vigilant readiness that guide human and animal behaviour during survival-salient situations. Categorical models of emotions posit neurally and physiologically distinct basic human emotions (anger, fear, disgust, happiness, sadness and surprise) that govern different survival functions. Opioid receptors are expressed abundantly in the mammalian emotion circuit, and the opioid system modulates a variety of functions related to arousal and motivation. Yet, its specific contribution to different basic emotions has remained poorly understood. Here, we review how the endogenous opioid system and particularly the μ receptor contribute to emotional processing in humans. Activation of the endogenous opioid system is consistently associated with both pleasant and unpleasant emotions. In general, exogenous opioid agonists facilitate approach-oriented emotions (anger, pleasure) and inhibit avoidance-oriented emotions (fear, sadness). Opioids also modulate social bonding and affiliative behaviour, and prolonged opioid abuse may render both social bonding and emotion recognition circuits dysfunctional. However, there is no clear evidence that the opioid system is able to affect the emotions associated with surprise and disgust. Taken together, the opioid systems contribute to a wide array of positive and negative emotions through their general ability to modulate the approach versus avoidance motivation associated with specific emotions. Because of the protective effects of opioid system-mediated prosociality and positive mood, the opioid system may constitute an important factor contributing to psychological and psychosomatic resilience. LINKED ARTICLES: This article is part of a themed section on Emerging Areas of Opioid Pharmacology. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.14/issuetoc.
© 2017 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28394427      PMCID: PMC6016642          DOI: 10.1111/bph.13812

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  125 in total

1.  Experimentally induced anger, cardiovascular reactivity, and pain sensitivity.

Authors:  S A Janssen; P Spinhoven; J F Brosschot
Journal:  J Psychosom Res       Date:  2001-09       Impact factor: 3.006

2.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

3.  Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.

Authors:  Tomi Karjalainen; Lauri Tuominen; Sandra Manninen; Kari K Kalliokoski; Pirjo Nuutila; Iiro P Jääskeläinen; Riitta Hari; Mikko Sams; Lauri Nummenmaa
Journal:  Soc Cogn Affect Neurosci       Date:  2016-04-06       Impact factor: 3.436

4.  Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (OPRM1) in adult healthy volunteers and psychiatric patients.

Authors:  Alfonso Troisi; Giovanni Frazzetto; Valeria Carola; Giorgio Di Lorenzo; Mariangela Coviello; Francesca R D'Amato; Anna Moles; Alberto Siracusano; Cornelius Gross
Journal:  Soc Neurosci       Date:  2010-05-17       Impact factor: 2.083

5.  Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations.

Authors:  Sandra D Comer; James P Zacny; Robert H Dworkin; Dennis C Turk; George E Bigelow; Richard W Foltin; Donald R Jasinski; Edward M Sellers; Edgar H Adams; Robert Balster; Laurie B Burke; Igor Cerny; Robert D Colucci; Edward Cone; Penney Cowan; John T Farrar; David J Haddox; Jennifer A Haythornthwaite; Sharon Hertz; Gary W Jay; Chris-Ellyn Johanson; Roderick Junor; Nathaniel P Katz; Michael Klein; Ernest A Kopecky; Deborah B Leiderman; Michael P McDermott; Charles O'Brien; Alec B O'Connor; Pamela P Palmer; Srinivasa N Raja; Bob A Rappaport; Christine Rauschkolb; Michael C Rowbotham; Cristina Sampaio; Beatrice Setnik; Marta Sokolowska; Joseph W Stauffer; Sharon L Walsh
Journal:  Pain       Date:  2012-09-19       Impact factor: 6.961

6.  Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.

Authors:  Susan E Kennedy; Robert A Koeppe; Elizabeth A Young; Jon-Kar Zubieta
Journal:  Arch Gen Psychiatry       Date:  2006-11

7.  The biology of social attachments: opiates alleviate separation distress.

Authors:  J Panksepp; B Herman; R Conner; P Bishop; J P Scott
Journal:  Biol Psychiatry       Date:  1978-10       Impact factor: 13.382

8.  Endogenous opioids may buffer effects of anger arousal on sensitivity to subsequent pain.

Authors:  John W Burns; Stephen Bruehl; Ok Y Chung; Edward Magid; Melissa Chont; James K Goodlad; Wesley Gilliam; Justin Matsuura; Kristin Somar
Journal:  Pain       Date:  2009-08-13       Impact factor: 6.961

9.  Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts.

Authors:  L LASAGNA; J M VON FELSINGER; H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-03-19

10.  Effects of amphetamine on the human brain opioid system--a positron emission tomography study.

Authors:  Joar Guterstam; Nitya Jayaram-Lindström; Simon Cervenka; J James Frost; Lars Farde; Christer Halldin; Johan Franck
Journal:  Int J Neuropsychopharmacol       Date:  2012-08-29       Impact factor: 5.176

View more
  31 in total

1.  Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system.

Authors:  Tiina Saanijoki; Lauri Nummenmaa; Jetro J Tuulari; Lauri Tuominen; Eveliina Arponen; Kari K Kalliokoski; Jussi Hirvonen
Journal:  Hum Brain Mapp       Date:  2018-06-08       Impact factor: 5.038

2.  Cognitive and socio-cognitive functioning of chronic non-medical prescription opioid users.

Authors:  Sara L Kroll; Emilija Nikolic; Franziska Bieri; Michael Soyka; Markus R Baumgartner; Boris B Quednow
Journal:  Psychopharmacology (Berl)       Date:  2018-10-11       Impact factor: 4.530

3.  Novel Dimethyltyrosine-Tetrahydroisoquinoline Peptidomimetics with Aromatic Tetrahydroisoquinoline Substitutions Show in Vitro Kappa and Mu Opioid Receptor Agonism.

Authors:  Deanna Montgomery; Jessica P Anand; Nicholas W Griggs; Thomas J Fernandez; Joshua G Hartman; Ashley A Sánchez-Santiago; Irina D Pogozheva; John R Traynor; Henry I Mosberg
Journal:  ACS Chem Neurosci       Date:  2019-07-01       Impact factor: 4.418

4.  Feeding Releases Endogenous Opioids in Humans.

Authors:  Jetro J Tuulari; Lauri Tuominen; Femke E de Boer; Jussi Hirvonen; Semi Helin; Pirjo Nuutila; Lauri Nummenmaa
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

5.  Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.

Authors:  Jarkko Johansson; Jussi Hirvonen; Zsófia Lovró; Laura Ekblad; Valtteri Kaasinen; Olli Rajasilta; Semi Helin; Jouni Tuisku; Saija Sirén; Mirka Pennanen; Arvind Agrawal; Roger Crystal; Petri J Vainio; Hannu Alho; Mika Scheinin
Journal:  Neuropsychopharmacology       Date:  2019-03-13       Impact factor: 7.853

Review 6.  A social affective neuroscience lens on placebo analgesia.

Authors:  Lauren Y Atlas
Journal:  Trends Cogn Sci       Date:  2021-09-16       Impact factor: 20.229

7.  Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.

Authors:  Tiina Saanijoki; Lauri Tuominen; Jetro J Tuulari; Lauri Nummenmaa; Eveliina Arponen; Kari Kalliokoski; Jussi Hirvonen
Journal:  Neuropsychopharmacology       Date:  2017-07-19       Impact factor: 7.853

8.  Dialectical Pain Management: Feasibility of a Hybrid Third-Wave Cognitive Behavioral Therapy Approach for Adults Receiving Opioids for Chronic Pain.

Authors:  Deborah Barrett; Carrie E Brintz; Amanda M Zaski; Mark J Edlund
Journal:  Pain Med       Date:  2021-05-21       Impact factor: 3.750

9.  Preoperative brain μ-opioid receptor availability predicts weight development following bariatric surgery in women.

Authors:  Henry K Karlsson; Lauri Tuominen; Semi Helin; Paulina Salminen; Pirjo Nuutila; Lauri Nummenmaa
Journal:  JCI Insight       Date:  2021-05-24

10.  Key considerations in the pharmacological management of treatment-resistant depression.

Authors:  Mani Yavi; Ioline D Henter; Lawrence T Park; Carlos Zarate
Journal:  Expert Opin Pharmacother       Date:  2021-07-21       Impact factor: 3.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.